Malaria treatment policies and drug efficacy in Haiti from 1955-2012

Journal of Pharmaceutical Policy and Practice

Thomas A Weppelmann¹  Michael E von Fricken¹  Alexander Existe¹  Bernard A Okech¹  Jennifer D Hosford¹ 

[1] 1Department of Environmental and Global Health, University of Florida, P.O. Box 100188, Gainesville, FL 32610, USA

关键词: Hispaniola;    Haiti;    Malaria treatment policy;    Chemotherapy;    Chloroquine;    Anti-malarial drug resistance;    Plasmodium falciparum;    Pyrimethamine;   

DOI  :  10.1186/2052-3211-6-10

学科分类：药理学

来源: BioMed Central

【 摘 要 】

Objectives

Chloroquine (CQ), after 67 years of use in Haiti, is still part of the official treatment policy for malaria. Several countries around the world have used CQ in the past due to its low incidence of adverse events, therapeutic efficacy, and affordability, but were forced to switch treatment policy due to the development of widespread CQ resistance. The purpose of this paper was to compile literature on malaria treatment policies and antimalarial drug efficacy in Haiti over 67-year period.

【 授权许可】

Unknown